Taking care of inpatients with fragility hip fractures: the hip-padua osteosarcopenia (Hip-POS) fracture liaison service model.

Fracture liaison service Fracture prevention Hip fractures Osteoporosis Sarcopenia

Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
06 Jul 2024
Historique:
received: 03 04 2024
accepted: 20 06 2024
medline: 7 7 2024
pubmed: 7 7 2024
entrez: 6 7 2024
Statut: aheadofprint

Résumé

Osteoporotic fragility fractures (FF), particularly those affecting the hip, represent a major clinical and socio-economic concern. These fractures can lead to various adverse outcomes, which may be exacerbated by the presence of sarcopenia, especially among older and frail patients. Early identification of patients with FF is crucial for implementing effective diagnostic and therapeutic strategies to prevent subsequent fractures and their associated consequences. The Hip-POS program, implemented at Azienda Ospedale-Università Padova, is a Fracture Liaison Service (FLS) program to evaluate patients aged > 50 years old admitted with fragility hip fractures, involving an interdisciplinary team. After the identification of patients with hip fractures in the Emergency Department, a comprehensive evaluation is conducted to identify risk factors for further fractures, and to assess the main domains of multidimensional geriatric assessment, including muscle status. Patients are then prescribed with anti-fracture therapy, finally undergoing periodic follow-up visits. During the first five months, a total of 250 patients were evaluated (70.4% women, median age 85 years). Following assessment by the Hip-POS team, compared to pre-hospitalization, the proportion of patients not receiving antifracture therapy decreased significantly from 60 to 21%. The prescription rates of vitamin D and calcium increased markedly from 29.6% to 81%. We introduced the Hip-POS program for the care of older adults with hip fractures. We aspire that our model will represent a promising approach to enhancing post-fracture care by addressing the multifactorial nature of osteoporosis and its consequences, bridging the gap in secondary fracture prevention, and improving patient outcomes.

Identifiants

pubmed: 38971949
doi: 10.1007/s40618-024-02425-z
pii: 10.1007/s40618-024-02425-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Carlotta Andaloro (C)
Giulia Bano (G)
Deris Gianni Boemo (DG)
Ester Bukli (E)
Davide Cannavò (D)
Alberta Cecchinato (A)
Martina Dall'Agnol (M)
Marina Rui (M)
Mario Degan (M)
Marta Dianin (M)
Martin Diogo (M)
Michela Ferrarese (M)
Claudia Finamoni (C)
Francesca Guidolin (F)
Mario Rosario Lo Storto (MRL)
Elena Marigo (E)
Stefano Masiero (S)
Caterina Mian (C)
Maria Vittoria Nesoti (MV)
Mor Peleg Falb (MP)
Cristina Russo (C)
Cristina Simonato (C)
Giulia Termini (G)
Hillary Veronese (H)
Francesca Zanchetta (F)
Chiara Ziliotto (C)

Informations de copyright

© 2024. The Author(s).

Références

Kanis JA (1997) Diagnosis of osteoporosis. Osteoporos Int 7:108–116. https://doi.org/10.1007/bf03194355
doi: 10.1007/bf03194355
Corrao G, Biffi A, Porcu G et al (2023) Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021. Front Endocrinol 14:1137671. https://doi.org/10.3389/fendo.2023.1137671
doi: 10.3389/fendo.2023.1137671
Borgström F, Karlsson L, Ortsäter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59. https://doi.org/10.1007/s11657-020-0706-y
doi: 10.1007/s11657-020-0706-y pubmed: 32306163 pmcid: 7166207
Piscitelli P, Neglia C, Feola M et al (2020) Updated incidence and costs of hip fractures in elderly Italian population. Aging Clin Exp Res 32:2587–2593. https://doi.org/10.1007/s40520-020-01497-0
doi: 10.1007/s40520-020-01497-0 pubmed: 32056151
Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Risk of second hip fracture persists for years after initial trauma. Bone 75:72–76. https://doi.org/10.1016/j.bone.2015.02.003
doi: 10.1016/j.bone.2015.02.003 pubmed: 25681701
Schemitsch E, Adachi JD, Brown JP et al (2022) Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporos Int 33:113–122. https://doi.org/10.1007/s00198-021-06080-5
doi: 10.1007/s00198-021-06080-5 pubmed: 34379148
Kanis JA, Cooper C, Rizzoli R et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44. https://doi.org/10.1007/s00198-018-4704-5
doi: 10.1007/s00198-018-4704-5 pubmed: 30324412
Camacho PM, Petak SM, Binkley N et al (2020) American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update. Endocr Pr 26:1–46. https://doi.org/10.4158/gl-2020-0524suppl
doi: 10.4158/gl-2020-0524suppl
Rossini M, Adami S, Bertoldo F et al (2016) Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo 68:1–39. https://doi.org/10.4081/reumatismo.2016.870
doi: 10.4081/reumatismo.2016.870 pubmed: 27339372
Åkesson KE, Ganda K, Deignan C et al (2022) Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends. Osteoporos Int 33:1659–1676. https://doi.org/10.1007/s00198-022-06358-2
doi: 10.1007/s00198-022-06358-2 pubmed: 35325260 pmcid: 8943355
Degli Esposti L, Saragoni S, Perrone V et al (2020) <p>Economic burden of osteoporotic patients with fracture: effect of treatment with or without calcium/vitamin D supplements</p>. Nutr Diet Suppl 12:21–30. https://doi.org/10.2147/nds.s234911
doi: 10.2147/nds.s234911
Tarantino U, Greggi C, Visconti VV et al (2023) Fracture liaison service model: project design and accreditation. Osteoporos Int 34:339–348. https://doi.org/10.1007/s00198-022-06600-x
doi: 10.1007/s00198-022-06600-x pubmed: 36422656
Li N, Hiligsmann M, Boonen A et al (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32:1517–1530. https://doi.org/10.1007/s00198-021-05911-9
doi: 10.1007/s00198-021-05911-9 pubmed: 33829285 pmcid: 8376729
Gadelha AB, Neri SGR, de Oliveira RJ et al (2018) Severity of sarcopenia is associated with postural balance and risk of falls in community-dwelling older women. Exp Aging Res 44:258–269. https://doi.org/10.1080/0361073x.2018.1449591
doi: 10.1080/0361073x.2018.1449591 pubmed: 29558320
Kirk B, Zanker J, Duque G (2020) Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers. J Cachexia, Sarcopenia Muscle 11:609–618. https://doi.org/10.1002/jcsm.12567
doi: 10.1002/jcsm.12567 pubmed: 32202056
Linn BS, Linn MW, Gruel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16:622–626. https://doi.org/10.1111/j.1532-5415.1968.tb02103.x
doi: 10.1111/j.1532-5415.1968.tb02103.x pubmed: 5646906
Katz S (1983) Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 31:721–727. https://doi.org/10.1111/j.1532-5415.1983.tb03391.x
doi: 10.1111/j.1532-5415.1983.tb03391.x pubmed: 6418786
Graf C (2009) The lawton instrumental activities of daily living (IADL) scale. Medsurg Nurs : Off J Acad Méd-Surg Nurses 18:315–316
Vellas B, Guigoz Y, Garry PJ et al (1999) The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116–122. https://doi.org/10.1016/s0899-9007(98)00171-3
doi: 10.1016/s0899-9007(98)00171-3 pubmed: 9990575
Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients†. J Am Geriatr Soc 23:433–441. https://doi.org/10.1111/j.1532-5415.1975.tb00927.x
doi: 10.1111/j.1532-5415.1975.tb00927.x pubmed: 1159263
Bliss MR, McLaren R, Exton-Smith AN (1966) Mattresses for preventing pressure sores in geriatric patients. Mon Bull Minist Heal Public Heal Lab Serv 25:238–268
Pilotto A, Ferrucci L, Franceschi M et al (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 11:151–161. https://doi.org/10.1089/rej.2007.0569
doi: 10.1089/rej.2007.0569 pubmed: 18173367
Adami G, Biffi A, Porcu G et al (2023) A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS. J Endocrinol Investig 46:2287–2297. https://doi.org/10.1007/s40618-023-02082-8
doi: 10.1007/s40618-023-02082-8
Chumlea WC, Roche AF, Steinbaugh ML (1985) Estimating stature from knee height for persons 60 to 90 years of age. J Am Geriatr Soc 33:116–120. https://doi.org/10.1111/j.1532-5415.1985.tb02276.x
doi: 10.1111/j.1532-5415.1985.tb02276.x pubmed: 3968366
(2011) World Health Organization. Waist circumference and waist-hip ratio: Report of a WHO expert consultation Geneva 8–11 December 2008
Haase J (1946) Nutrition in dentistry. Dent Stud 24:16–20
pubmed: 21006989
Kanis JA, Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368–381. https://doi.org/10.1007/bf01622200
doi: 10.1007/bf01622200 pubmed: 7696835
Kyle UG, Genton L, Karsegard L et al (2001) Single prediction equation for bioelectrical impedance analysis in adults aged 20–94 years. Nutrition 17:248–253. https://doi.org/10.1016/s0899-9007(00)00553-0
doi: 10.1016/s0899-9007(00)00553-0 pubmed: 11312069
Fratture del femore prossimale nell’anziano. Linee Guida Società Italiana di Ortopedia e Traumatologia (SIOT). 2021. https://siot.it/lineeguida-fratturafemore2021
Volkert D, Beck AM, Cederholm T et al (2019) ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 38:10–47. https://doi.org/10.1016/j.clnu.2018.05.024
doi: 10.1016/j.clnu.2018.05.024 pubmed: 30005900
Agenzia Italiana del Farmaco (AIFA) (2023) Nota 79. https://www.aifa.gov.it/nota-79 . Accessed 20 Dec
Ceolin C, Bano G, Biz C, Dianin M, Bedogni M, Guarnaccia A, Berizzi A, Ruggieri P, Coin A, Sergi G (2023) Functional autonomy and 12-month mortality in older adults with proximal femoral fractures in an orthogeriatric setting: risk factors and gender differences. Aging Clin Exp Res 35(5):1063–1071. https://doi.org/10.1007/s40520-023-02378-y
doi: 10.1007/s40520-023-02378-y pubmed: 36892795
Vogliotti E, Ceolin C, Valenti M, Vanin J, Campodall’Orto C, Tonon M, Zanforlini BM, Curreri C, Devita M, De Rui M, Coin A, Cillo U, Burra P, Angeli P, Sergi G (2023) Can the multidimensional prognostic index (MPI) be a predictive instrument for mortality in older adult liver transplant candidates? European geriatric Med 14(4):851–859. https://doi.org/10.1007/s41999-023-00826-6
doi: 10.1007/s41999-023-00826-6
Veronese N, Smith L, Zigoura E et al (2022) Multidimensional prognostic index and the risk of fractures: an 8-year longitudinal cohort study in the osteoarthritis initiative. Arch Osteoporos 17:5. https://doi.org/10.1007/s11657-021-01015-3
doi: 10.1007/s11657-021-01015-3
Archunan MW, Subhash S, Attwood J et al (2021) Nottingham hip fracture score: does it predict mortality in distal femoral fracture patients? Cureus 13:e19139. https://doi.org/10.7759/cureus.19139
doi: 10.7759/cureus.19139 pubmed: 34873498 pmcid: 8635683
Agarwal G, Milan C, Mohsin Z et al (2022) Multiple myeloma screening within a fracture liaison service (FLS). Osteoporos Int 33:937–941. https://doi.org/10.1007/s00198-021-06233-6
doi: 10.1007/s00198-021-06233-6 pubmed: 34825920
Degli Esposti L, Girardi A, Saragoni S et al (2019) Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk. Endocrine 64:367–377. https://doi.org/10.1007/s12020-018-1824-9
doi: 10.1007/s12020-018-1824-9 pubmed: 30515678
Barton DW, Piple AS, Smith CT, Moskal SA, Carmouche JJ (2021) The clinical impact of fracture liaison services: a systematic review. Geriatric Orthopaedic Surg Rehabilit 12:2151459320979978. https://doi.org/10.1177/2151459320979978
doi: 10.1177/2151459320979978
Fan W, Leder BZ, Mannstadt M et al (2023) Safety of inpatient zoledronic acid in the immediate postfracture setting. J Clin Endocrinol Metab 108:e1282–e1288. https://doi.org/10.1210/clinem/dgad295
doi: 10.1210/clinem/dgad295 pubmed: 37227016
Sargin S, Konya MN, Gulcu A, Aslan A (2019) Effects of zoledronic acid treatment on fracture healing, morbidity and mortality in elderly patients with osteoporotic hip fractures. Strat Trauma Limb Reconstr 14:126–131. https://doi.org/10.5005/jp-journals-10080-1439
doi: 10.5005/jp-journals-10080-1439
Colón-Emeric C, Nordsletten L, Olson S et al (2011) Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int 22:2329–2336. https://doi.org/10.1007/s00198-010-1473-1
doi: 10.1007/s00198-010-1473-1 pubmed: 21153021
Li YT, Cai HF, Zhang ZL (2015) Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 26:431–441. https://doi.org/10.1007/s00198-014-2903-2
doi: 10.1007/s00198-014-2903-2 pubmed: 25266485
Kim TY, Ha YC, Kang BJ et al (2012) Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Jt Surg Br 94-B(7):956–960. https://doi.org/10.1302/0301-620x.94b7.29079
doi: 10.1302/0301-620x.94b7.29079
Delbar A, Pflimlin A, Delabrière I et al (2021) Persistence with osteoporosis treatment in patients from the lille university hospital fracture liaison service. Bone 144:115838. https://doi.org/10.1016/j.bone.2020.115838
doi: 10.1016/j.bone.2020.115838 pubmed: 33385615
Wu CH, Kao IJ, Hung WC et al (2018) Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature. Osteoporos Int 29:1227–1242. https://doi.org/10.1007/s00198-018-4411-2
doi: 10.1007/s00198-018-4411-2 pubmed: 29460102

Auteurs

G P Arcidiacono (GP)

Clinica Medica 1, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

C Ceolin (C)

Department of Medicine - DIMED, Division of Metabolic Disease (DIMED), University of Padova, Padua, Italy. chiara.ceolin.1@phd.unipd.it.
Geriatric Unit, Department of Medicine, University Hospital of Padova, Padua, Italy. chiara.ceolin.1@phd.unipd.it.
Department of Neurobiology, Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden. chiara.ceolin.1@phd.unipd.it.

S Sella (S)

Clinica Medica 1, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

V Camozzi (V)

Endocrinology Unit, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

A Bertocco (A)

Geriatric Unit, Department of Medicine, University Hospital of Padova, Padua, Italy.

M O Torres (MO)

Clinica Medica 1, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

M G Rodà (MG)

Orthopedics and Orthopedic Oncology Unit, Azienda Ospedale-Università Padova, Padua, Italy.

M Cannito (M)

Endocrinology Unit, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

A Berizzi (A)

Orthopedics and Traumatology Unit, Azienda Ospedale-Università Padova, Padua, Italy.

G Romanato (G)

Orthopedics and Traumatology Unit, Azienda Ospedale-Università Padova, Padua, Italy.

A Venturin (A)

Physical Medicine and Rehabilitation Unit, Azienda Ospedale-Università Padova, Padua, Italy.

V Cianci (V)

Emergency Department, Azienda Ospedale-Università Padova, Padua, Italy.

A Pizziol (A)

Emergency Department, Azienda Ospedale-Università Padova, Padua, Italy.

E Pala (E)

Orthopedics and Orthopedic Oncology Unit, Azienda Ospedale-Università Padova, Padua, Italy.

M Cerchiaro (M)

Orthopedics and Orthopedic Oncology Unit, Azienda Ospedale-Università Padova, Padua, Italy.

S Savino (S)

Department of Medicine, Università Di Padova, Padua, Italy.

M Tessarin (M)

Department of Directional Hospital Management, Azienda Ospedale-Università Padova, Padua, Italy.

P Simioni (P)

Clinica Medica 1, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

G Sergi (G)

Geriatric Unit, Department of Medicine, University Hospital of Padova, Padua, Italy.

P Ruggieri (P)

Orthopedics and Orthopedic Oncology Unit, Azienda Ospedale-Università Padova, Padua, Italy.

S Giannini (S)

Clinica Medica 1, Department of Medicine, Azienda Ospedale-Università Padova, Padua, Italy.

Classifications MeSH